These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15634275

  • 21. Collaborative study for the establishment of Infliximab Biological Reference Preparation Batch 1.
    Wadhwa M, Rigsby P, Behr-Gross ME.
    Pharmeur Bio Sci Notes; 2020; 2020():49-52. PubMed ID: 32459170
    [Abstract] [Full Text] [Related]

  • 22. International collaborative study to establish the 3rd International Standard for Streptokinase.
    Sands D, Whitton CM, Longstaff C.
    J Thromb Haemost; 2004 Aug; 2(8):1411-5. PubMed ID: 15304048
    [Abstract] [Full Text] [Related]

  • 23. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L, Desai T, Heath A, Poole S, Crivellone M, Hauck W, Ambrose M, Morris T, Daas A, Rautmann G, Buchheit KH, Spieser JM, Terao E.
    Pharmeur Bio Sci Notes; 2015 Aug; 2015():73-98. PubMed ID: 26830160
    [Abstract] [Full Text] [Related]

  • 24. Collaborative study to establish a new biological reference preparation for prekallikrein activator.
    Longstaff C, Behr-Gross ME, Daas A, Lackner F.
    Pharmeuropa Bio; 2005 Sep; 2005(1):1-12. PubMed ID: 16336933
    [Abstract] [Full Text] [Related]

  • 25. New BRP for human plasma calibrated for coagulation factors V, VIII, XI and XIII - collaborative study for establishment of batches 1 and 2.
    Bayer P, Daas A, Milne C.
    Pharmeur Bio Sci Notes; 2011 Nov; 2011(2):16-25. PubMed ID: 22225765
    [Abstract] [Full Text] [Related]

  • 26. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
    Ingerslev J, Jankowski MA, Weston SB, Charles LA, ReFacto Field Study Participants.
    J Thromb Haemost; 2004 Apr; 2(4):623-8. PubMed ID: 15102018
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Discrepancies in potency assessment of recombinant FVIII concentrates.
    Barrowcliffe TW, Raut S, Hubbard AR.
    Haemophilia; 1998 Jul; 4(4):634-40. PubMed ID: 9873806
    [Abstract] [Full Text] [Related]

  • 29. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D, Winsnes R, Rigsby P, Gaines-Das R.
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [Abstract] [Full Text] [Related]

  • 30. Establishment of the human coagulation factor VII concentrate European Pharmacopoeia biological reference preparation batch 1.
    Dodt J, Hunfeld A, Daas A, Buchheit KH.
    Pharmeuropa Bio; 2006 Nov; 2006(1):15-22. PubMed ID: 17270128
    [Abstract] [Full Text] [Related]

  • 31. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed.
    Sesardic D, Winsnes R, Rigsby P, Tierney R, Gaines-Das R.
    Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430
    [Abstract] [Full Text] [Related]

  • 32. Collaborative study for the establishment of the Ph. Eur. BRP batch 1 for anti-vaccinia immunoglobulin.
    Fuchs F, Poirier B, Leparc-Goffart I, Buchheit KH.
    Pharmeuropa Bio; 2005 Sep; 2005(1):13-8. PubMed ID: 16336934
    [Abstract] [Full Text] [Related]

  • 33. Joint WHO/EDQM Collaborative study for the establishment of WHO 3rd International Standard and Ph. Eur. Biological Reference Preparation for Prekallikrein activator in albumin batch 7.
    Fox B, Regourd E, Rigsby P, Longstaff C, Terao E.
    Pharmeur Bio Sci Notes; 2024 Sep; 2024():106-126. PubMed ID: 39010792
    [Abstract] [Full Text] [Related]

  • 34. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega.
    Meager A, Gaines Das R, Zoon K, Mire-Sluis A.
    J Immunol Methods; 2001 Nov 01; 257(1-2):17-33. PubMed ID: 11687235
    [Abstract] [Full Text] [Related]

  • 35. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
    Morgeaux S, Chagnaud P, Variot P, Le Tallec D, Behr-Gross ME.
    Pharmeur Bio Sci Notes; 2020 Nov 01; 2020():161-202. PubMed ID: 32788038
    [Abstract] [Full Text] [Related]

  • 36. Collaborative study for the establishment of Etanercept Biological Reference Preparation Batch 1.
    Wadhwa M, Rigsby P, Behr-Gross ME.
    Pharmeur Bio Sci Notes; 2020 Nov 01; 2020():203-205. PubMed ID: 33021469
    [Abstract] [Full Text] [Related]

  • 37. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR, Rigsby P, Barrowcliffe TW.
    Thromb Haemost; 2001 Apr 01; 85(4):634-8. PubMed ID: 11341497
    [Abstract] [Full Text] [Related]

  • 38. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A, Das RG.
    J Immunol Methods; 2005 Nov 30; 306(1-2):1-15. PubMed ID: 16226271
    [Abstract] [Full Text] [Related]

  • 39. A collaborative study to establish the 5th International Standard for Unfractionated Heparin.
    Gray E, Walker AD, Mulloy B, Barrowcliffe TW.
    Thromb Haemost; 2000 Dec 30; 84(6):1017-22. PubMed ID: 11154108
    [Abstract] [Full Text] [Related]

  • 40. A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation.
    Thorpe SJ, Sands D, Fox B, Behr-Gross ME, Schäffner G, Yu MW.
    Vox Sang; 2003 Nov 30; 85(4):313-21. PubMed ID: 14633258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.